technology
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
arstechnica.com • 19 Aug 2026, 16:53
The vaccine reportedly thwarted the cancer's return and spread.
Les originalartikkelen
Relaterte artikler etter nøkkelord
vaccine
spread
- Can We Control What AI Knows? Inside the "Restraint Abliteration" Breakthrough
- Microsoft finally patches critical one-click Copilot vulnerability, more than eight months after learning of it
- GitHub restores services after nearly 8-hour outage disrupts Actions, APIs, PRs and Copilot
- A viral diet and warm oceans emptied the canned sardine shelf